IDH1 and astrocytoma (excluding glioblastoma): Thus, mutations in the isocitrate dehydrogenase genes IDH1 and IDH2 define specific entities, associated with lower histologic grades and better prognosis when compared to IDH-wild-type astrocytomas [3].